Literature DB >> 32388946

[Screening and management of asymptomatic infection of 2019-novel coronavirus].

Z B Hu1, C Song1.   

Abstract

At present, the prevention and control of COVID-19 in China has entered a critical period. Recently, various areas outside Hubei Province have gradually begun to resume work and production, but the development of the epidemic situation is still uncertain and complex. A few days ago, researchers gradually began to pay attention to asymptomatic infection of 2019-novel coronavirus and described the disease process of asymptomatic infection and the possibility of being a source of infection. This provided a scientific basis for further optimizing and improving epidemic prevention and control measures. Paying attention to the screening and self-protection of high-risk groups and strengthening the level of detection should be helpful to the detection and management of asymptomatic infection.

Entities:  

Keywords:  2019-novel coronavirus; Infection

Mesh:

Year:  2020        PMID: 32388946     DOI: 10.3760/cma.j.cn112150-20200229-00220

Source DB:  PubMed          Journal:  Zhonghua Yu Fang Yi Xue Za Zhi        ISSN: 0253-9624


  3 in total

1.  Assessment and management of asymptomatic COVID-19 infection: A systematic review.

Authors:  Joshuan J Barboza; Diego Chambergo-Michilot; Mariana Velasquez-Sotomayor; Christian Silva-Rengifo; Carlos Diaz-Arocutipa; Jose Caballero-Alvarado; Franko O Garcia-Solorzano; Christoper A Alarcon-Ruiz; Leonardo Albitres-Flores; German Malaga; Patricia Schlagenhauf; Alfonso J Rodriguez-Morales
Journal:  Travel Med Infect Dis       Date:  2021-04-07       Impact factor: 20.441

Review 2.  Cross-disciplinary approaches to assist with nucleic acid testing for SARS-CoV-2.

Authors:  Shujuan Yang; Xiongfeng Pan; Dan Yuan; Peibin Zeng; Peng Jia
Journal:  Appl Microbiol Biotechnol       Date:  2021-08-23       Impact factor: 4.813

3.  A Large-Scale Screening Responding Sporadic Epidemic of COVID-19 in China by an Integrated Health-Care System.

Authors:  Xuru He; Xizhuo Sun; Fangfang Gong; Wenhai Li; Jinchun Lin; Hanqun Lin; Guangyu Hu
Journal:  Int J Integr Care       Date:  2022-03-23       Impact factor: 5.120

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.